It’s Dementia Awareness week this week so you can find out what BIA members are doing to tackle the issue on our Celebrating UK Bioscience page and watch our video case study here. Last week, the entire BIA staff  visited our charity of the Year Alzheimer’s Research UK and it was great for both teams to meet each other and to find out how we both work across the different departments.

The General Election campaign continues, and we look forward to sharing our analysis of the main parties manifestos in the coming week, however it has caused some changes to upcoming BIA events. The BIA and MHRA would like to let you know that our joint annual conference Innovation in life sciences in a changing and dynamic environment has been rescheduled and will now take place on Friday 14 July 2017, instead of polling day 8 June. The venue remains the Royal Society of Medicine in central London and we are pleased that the vast majority of our speakers have been able to move to this new date meaning that we will have a excellent agenda for the day. Please accept our sincere apologies for any inconvenience caused through this change of date, which is due to “purdah” restrictions on Government agencies during this period. If you were already registered for the original date, your place for the 14th July is confirmed. If you can no longer attend, cancellations must be made in writing by email to biaevents@bioindustry.org for a refund as soon as possible. Please note that you may send a colleague in your place and this should also be notified in writing. If we do not hear from you we will assume that you are attending and look forward to seeing on 14 July 2017.

Last week, I wrote to Ministers and Permanent Secretaries in the Departments for Health, Exiting the EU and Business, Energy and Industrial Strategy to highlight the action needed by government now to protect the UK’s ability to negotiate cooperation on medicines regulation with the EU post Brexit.  Ongoing close cooperation is in the best public health interests of patients both in the UK and the EU given the shared legacy of documentation, analysis and review and the scale and complexity of the technical aspects of medicines regulation.

I hope to be able to update further on all things Brexit and General Election at our next webinar on June 15th. And it will also be a key topic of discussion at our CEO and Investor forum in Oxford next week. It’s the last chance to book for what is set to be a great 24 hours of the latest insight and fantastic networking – looking forward to seeing many of you there.

Best,

Steve